The deletion of the pttg1 gene in the transgenic mouse (TRβPV/PV pttg1−/−) decreased vascular invasion accompanied by a decrease in FGFR1, FGF-2, and VEGF and decreased tumor mass, although it did not prevent tumor initiation [27]. The gene discussed is FGFR1; the disease is neoplasm.